Pharmacists told to diversify vax stocks as excess flu deaths hit five-year peak

Pharmacists have been reminded to order their flu jab stocks from more than one manufacturer to prevent supply issues amid the highest recorded excess deaths from influenza in five years.

Last year's flu season began earlier than usual and saw increased hopitalisations

The UK suffered 14,500 excess deaths associated with influenza infections in 2022/23 – the highest figure in five years, the UK Health Security Agency (UKHSA) revealed in last week’s (June 22) annual flu report.

The UKHSA said that the flu season began earlier than usual and saw increased hospitalisations – although it said that some of this may have been due to increased NHS testing compared to previous years.

Read more: Well Pharmacy launches private flu jab bookings early at £17.99

The news comes as the government has repeated its recommendation that pharmacies and other NHS contractors should buy their flu vaccine stock from more than one manufacturer "to mitigate against the risk of supply issues".

It came as part of a written parliamentary response from June 22, Lord Markham, parliamentary under-secretary for health and social care, who also said that vaccine deliveries will be “phased through the season” to reduce the risk of wastage, cold chain failure, and to cover shifting demand for jabs.

Dominant strain was “more severe” in elderly

The UKHSA attributed the severity of the last flu season to the dominant strain, influenza A(H3N2), which it said is “more severe in older age groups”. The health agency also said that evidence suggests social distancing measures during the COVID-19 pandemic led to “reduced flu circulation”, leading to people being “more susceptible” to influenza infection than usual.

Nevertheless, the UKHSA described last flu season’s vaccines as “well matched” to influenza A(H3N2). Its analysis found that vaccinations greatly reduced the risk of severe disease.

People aged over 65 reduced their risk of hospitalisation by flu by a quarter if they were vaccinated, while other adults saw their risk reduced by a third, and children by two-thirds.

Read more: Government scraps free flu jabs for 50-64-year-olds in 2023/24 season

The UKHSA said that, on average, there were “around 13,000” annual excess deaths associated with flu in the five to 10 years before the pandemic. The 2022 excess flu death toll marks the highest figure since the 2017/2018 season, when 22,500 people died. 

Well Pharmacy opens up flu jab bookings

Earlier this month (June 2), C+D reported that Well Pharmacy had opened its flu vaccination service to bookings “earlier than usual” for the service launching later this year, and Rowlands confirmed to C+D that it would launch its flu vaccination service from September 1.

The annual flu letter was published on May 25, and announced that people aged 50-64 will not be eligible for a free flu jab in the 2023/24 season.

The UKHSA will develop patient group directions (PGDs) and a national protocol that will become available before the programme launches, the letter said.

Read more: Flu wars: Which pharmacy chain is offering the cheapest jabs?

And in January, the government announced that a record number of people over 65 had received flu vaccinations, with 81.4% receiving a flu vaccination that season, according to UKHSA figures.

The most recent flu season saw multiple offering flu vaccines at a low cost in a price war.

On January 9, Well Pharmacy announced that it would offer its private flu jab free of charge to all patients aged over 18 during a peak in hospital admissions.

James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

US pharmacy groups made billions from ‘critical drug’ price hikes

 
• By 

A US government report has found that three of the country’s largest pharmacy benefit managers (PBMs) “hiked costs” of “lifesaving drugs” including cancer and HIV treatments by “thousands of percent” between 2017 and 2022.

Coroner: Patient overdosed after pharmacy ‘welfare concern’ missed

 
• By 

A coroner has warned that the lack of “communication between primary and secondary care” may lead to the “early death” of more patients, after an NHS trust was not made aware of a pharmacy’s warning.

RPS planning to vote on ‘Royal College’ status in March

 
• By 

A vote on the Royal Pharmaceutical Society’s (RPS) bid to become a royal college is expected to be held in March, C+D has learned.

More from Clinical

Repeat paracetamol use linked to ‘serious complications’ in over-65s

 
• By 

A study of over half-a-million over-65s has found links between repeatedly taking paracetamol and complications including gastrointestinal bleeding and heart failure.

Strep A: Toddler died after ‘delay’ in receiving out-of-stock antibiotics, coroner warns

 
• By 

A toddler with a Strep A infection was given antibiotics too late after a pharmacist could not issue alternative medication during shortages due to restrictions, a coroner has found.